Aspiro Therapeutics is on a mission to revolutionize treatment for obstructive lung diseases by mimicking the protective power of CC16, a natural lung protein vital for healthy breathing. We are focused on developing advanced, disease-modifying therapies that target the underlying mechanisms of conditions like asthma and COPD, going beyond symptom relief to alter the natural course of these diseases.

By harnessing the protective properties of CC16, we aim to restore lung function and prevent disease progression, offering patients safer and more effective treatment options. Through innovation and a commitment to improving respiratory care, we strive to make a lasting impact on the lives of those affected by obstructive lung diseases.